Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Lxe408
2. N-(4-fluoro-3-(6-(3-methylpyridin-2-yl)-(1,2,4)triazolo(1,5-a)pyrimidin-2-yl)phenyl)-2,4-dimethyl-1,3-oxazole-5-carboxamide
1. Lxe408
2. 1799330-15-6
3. Chembl4748352
4. Lxe-408
5. 5-oxazolecarboxamide, N-(4-fluoro-3-(6-(3-methyl-2-pyridinyl)(1,2,4)triazolo(1,5-a)pyrimidin-2-yl)phenyl)-2,4-dimethyl-
6. N-(4-fluoro-3-(6-(3-methylpyridin-2-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)phenyl)-2,4-dimethyloxazole-5-carboxamide
7. Unii-oik6i0da01
8. Schembl16822697
9. Bdbm50546340
10. Hy-131350
11. Cs-0133456
| Molecular Weight | 443.4 g/mol |
|---|---|
| Molecular Formula | C23H18FN7O2 |
| XLogP3 | 3.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 443.15060100 g/mol |
| Monoisotopic Mass | 443.15060100 g/mol |
| Topological Polar Surface Area | 111 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 702 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A LXE408 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LXE408, including repackagers and relabelers. The FDA regulates LXE408 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LXE408 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A LXE408 supplier is an individual or a company that provides LXE408 active pharmaceutical ingredient (API) or LXE408 finished formulations upon request. The LXE408 suppliers may include LXE408 API manufacturers, exporters, distributors and traders.
LXE408 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of LXE408 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right LXE408 GMP manufacturer or LXE408 GMP API supplier for your needs.
A LXE408 CoA (Certificate of Analysis) is a formal document that attests to LXE408's compliance with LXE408 specifications and serves as a tool for batch-level quality control.
LXE408 CoA mostly includes findings from lab analyses of a specific batch. For each LXE408 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
LXE408 may be tested according to a variety of international standards, such as European Pharmacopoeia (LXE408 EP), LXE408 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (LXE408 USP).
LOOKING FOR A SUPPLIER?
